chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her middle finger on the brass knuckle which felt swollen and painful; her middle finger on the brass knuckle which felt swollen and painful; the very tip of her middle finger there is red bump with a sharp pain; the very tip of her middle finger there is red bump with a sharp pain; nausea; sweaty; hot; body aches but without chills; tired; a little marble, a pea size place on her collarbone on the left side/the bump on her collarbone/you even touched it hurt; more sleepy than usual; This is a spontaneous report from a contactable consumer (patient). A 31-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 16Apr2021 10:00 (Batch/Lot Number: EW0169) at the age of 31-years-old as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on 27Mar2021 10:00 AM at Left Arm for covid-19 immunization, the patient also received flu shot on 10Mar2021. The patient had experienced side effect specifically on her middle finger on the brass knuckle which felt swollen and painful on 18Apr2021. She wanted to know if she can have an X-ray done and if it will interact with the vaccine. Now she was having problems with one of her fingers. Reported after the second dose she felt fine. Then the next morning on 17Apr2021 on the left side, her left arm and shoulder, she went to rub it and felt a little marble, a pea size place on her collarbone on the left side. Yesterday on 18Apr2021, the very tip of her middle finger there is red bump with a sharp pain. Add it is the middle finger, the last knuckle closest to the nail. There was a sharp pain, and couldn't move it, and it felt like there was a needle inside trying to come out. Adds it only hurts when she tries to move it. Added she has also felt nausea; sweaty and hot; body aches but without chills, body tired ache on 17Apr2021; more sleepy than usual on 16Apr2021. With regard to the bump on her collarbone, she stated the bump was still there but the pain was down. Before if you even touched it hurt. Adds her knuckle was still red and more swollen and if you touch it it really hurts. The nausea came in waves since she woke up the next day after the second dose. The body aches also come and go, but now they are not as bad. Adds she usually does not sleep as much but she can tell it is more now. She is planning to go the clinic to have her finger looked at. The outcome of the events 'more sleepy than usual', 'body aches but without chills' was recovering, the outcome of the event tired was unknown, and the outcome of the other events was not recovered.  No follow-up attempts are needed. No further information is expected.
felt very sick; Persistent sore throat; Constant diarrhea multiple times for four days; discomfort; weak; General malaise; Worn out; "little fever; Fatigue/ tired; terrible intense head ache; chills; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (felt very sick), OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort) and ASTHENIA (weak) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Obesity and Tachycardia. Concomitant products included WARFARIN, CHOLESTEROL, BENZOYL PEROXIDE (BP) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021 at 12:00 PM, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced HEADACHE (terrible intense head ache), CHILLS (chills) and FATIGUE (Fatigue/ tired). On 09-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort), ASTHENIA (weak), MALAISE (General malaise), FATIGUE (Worn out) and PYREXIA ("little fever). On an unknown date, the patient experienced ILLNESS (felt very sick). At the time of the report, ILLNESS (felt very sick), OROPHARYNGEAL PAIN (Persistent sore throat), DIARRHOEA (Constant diarrhea multiple times for four days), DISCOMFORT (discomfort), ASTHENIA (weak), MALAISE (General malaise), FATIGUE (Worn out), CHILLS (chills), PYREXIA ("little fever) and FATIGUE (Fatigue/ tired) outcome was unknown and HEADACHE (terrible intense head ache) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included patient's pharmacist suggested not to take any medication as treatment to the symptoms.
Patient received vaccine beyond 30 days on the fridge; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine beyond 30 days on the fridge) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine beyond 30 days on the fridge). On 27-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine beyond 30 days on the fridge) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.   This case was linked to MOD-2021-338604 (Patient Link).
expired Menveo administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 9-month-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAA585A, expiry date 30th August 2022) for prophylaxis.   On 2nd September 2022, the patient received Menveo. On 2nd September 2022, unknown after receiving Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 06-SEP-2022 Reporter's comment: The nurse administered to the patient an expired dose of Menveo by error. The reporter consented to follow-up via postal. Additional Supportive Information:  The patient received a dose of Menveo which was already expired, which led to expired vaccine used.
headache; tiredness; ringing in my ear; Muscle ache; This is a spontaneous report from a non-contactable consumer reported for herself. A 45-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration at left arm on 29-Jan-2021 14:30 as a 1st dose single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient had no allergies to medications, food, or other products. The patient had not diagnosed with COVID-19 prior to vaccination and since vaccination. On 30Jan2021 the patient experienced Muscle ache, headache, tiredness, ringing in my ear. Outcome of the events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
An expired vaccine was given to a patient/Vial had been punctured at room temperature for almost 26 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (An expired vaccine was given to a patient/Vial had been punctured at room temperature for almost 26 hours) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K212A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 17-Mar-2022 at 2:44 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (An expired vaccine was given to a patient/Vial had been punctured at room temperature for almost 26 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (An expired vaccine was given to a patient/Vial had been punctured at room temperature for almost 26 hours) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products reported included unspecified high blood pressure medication and high cholesterol medications.  Concurrent condition included high cholesterol.  Vial had been punctured at room temperature for almost 26 hours. Vial was open at 1:06 PM on 16-Mar-2022, and administered to the patient on 17-Mar-2022 at 2:44 PM.  No treatment medications were reported.
Solid red rash with itching under both arms, starting in the afternoon and still present the next morning.
S/P VACCINE, STARTED WITH FEVER OF 101.2, CHILLS, RESPIRATORY WHEEZING, AND BODY ACHES AT 2100. PRN TYLENOL GIVEN AT 2116, TEMP DECREASED TO 100.1. NURSE PRACTIONER MADE AWARE WITH NEW ORDER FOR DUONEBS. TODAY ON 5/21 SHE STATES SHE STILL FEELS ACHES, HAS NOT HAD ANY TYLENOL TODAY- MORNING TEMP WAS 99.1 AND CURRENTLY IT IS  98.4.
tenderness in rt arm p/inj; approx 4" area of erythema & edema the following day; some nausea w/o vomiting; given 2 days bed rest; compazine tablets, Motrin, APAP; treated @ hosp;
Red rash surrounding shot area about 4" diameter- fever and flu like symptoms Also had flu shot that day from another source. Still red rash-no fever.
APPROX. 20 SECONDS AFTER RECVING HPV VACCINE #2 & HEPA #1 CHILD REPORTED FEELING NAUSEA & DIZZINESS, BECAME PALE & BRADYCARDIC AT 45BPM. SYMPS APPROX 10 MIN .  SUPINE, & ORAL FLUIDS.
I had experienced a severe vertigo episode the first night of DOSE 1 of Pfizer at approximately 11:30 PM the day of vaccination.  Approximately 48 hours after DOSE 2 of Pfizer vaccine I experienced a similar vertiginous episode which lasted for three days. For the next 2.5 months I continued to experience daily, brief, often debilitating episodes of vertigo. In addition I experienced gastrointestinal pain, sometimes severe. I still experience brief episodes of vertigo as an aftermath of this shot.
Allergic reaction; This is a spontaneous report from a non-contactable consumer (patient). A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and expiration date were not reported), via unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced allergic reaction to the first time around and it wasn't serious. The outcome of the event was unknown. The patient was querying if the second shot that they were getting is a little bit lighter or a heavier one.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Some fussiness for about 8 hours, post vax. While attempting to bathe child with sibling, child cried vigorously with red face then "began to grunt 2-3 times". Child became extremely pale and flaccid with perioral cyanosis. No loss of respiration or postictal state. Repeat episode about 1 hour, then 2 hours later, lasting 3-5 minutes each. Fever was 100F at physician's office. Full sepsis work-up was negative. Child was hospitalized for observation with probable dx of breath holding spell.
Janssen COVID-19 Vaccine EUA-symptoms experienced have been documented on this form prior to this item number.
red hard raised spot about 5 inches in diameter; red hard raised spot about 5 inches in diameter; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE ERYTHEMA (red hard raised spot about 5 inches in diameter) and VACCINATION SITE INDURATION (red hard raised spot about 5 inches in diameter) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concomitant products included THIAMAZOLE (METHIMAZOLE) and PROPRANOLOL for an unknown indication.    On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red hard raised spot about 5 inches in diameter) and VACCINATION SITE INDURATION (red hard raised spot about 5 inches in diameter). On 19-Mar-2021, VACCINATION SITE ERYTHEMA (red hard raised spot about 5 inches in diameter) and VACCINATION SITE INDURATION (red hard raised spot about 5 inches in diameter) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.   This case was linked to MOD-2021-361946 (Patient Link).
Experienced swelling under both eyes when I woke up this morning.; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 43-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 23Feb2021 15:45 (at the age of 43 years old) (Batch/Lot Number: EN 5318) as single dose for COVID-19 immunisation. Medical history included none. The patient has no known allergies. Concomitant medications included ascorbic acid, betacarotene, biotin, capsicum annuum fruit, colecalciferol, collagen marine, curcuma longa, cysteine hydrochloride, equisetum arvense, fallopia japonica, hyaluronic acid, iodine, keratin, lysine, methionine, piper nigrum, selenium, serenoa repens, tocotrienols nos, withania somnifera, zinc (NUTRAFOL), vitamin d3, iron, ascorbic acid (VITAMIN C ACID), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]). No other vaccines were received in fourweeks. On 25Feb2021 06:15 AM, the patient experienced swelling under both eyes when she woke up. The patient took benadryl (did not help) but ice pack helped. The patient was not diagnosed with COVID-19 prior to the vaccination and has not been tested for COVID-19 since the vaccination. Therapeutic measures were taken as a result of experienced swelling under both eyes when i woke up this morning. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Delayed skin reaction at injection site. Redness, itchy, hot, swollen, hard.
Pt reported painful blue-purple lump on palmar surface of R middle finger at crease of the PIP joint, onset 2-3 days after first dose of the Pfizer vaccine, diagnosed by this provider as a palmar digital vein thrombosis. No other precipitating factors such as trauma or exposure to intense vibrations to the finger or other causative factors could be identified. Pt without any history of clotting disorders. Pt healthy, not taking any medications. Pt reported that symptoms were improving at the time of her clinic presentation on 4/13/21.  Of note, pt reported her husband, who received the vaccine the same day, had very similar symptoms on the palmar surface of his 5th finger onset a few days after this patient.
hematoma in the area of administration; Anatomical site of injection: Her left elbow; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored Program. A 62-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular administered in the left elbow on 14Jun2021 (at the age of 62 years) (Batch/Lot Number: FA6780) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. When the patient received the first dose, she had a hematoma in the area of administration on an unspecified date. Anatomical site of injection was reported as "her left elbow" (pending clarification). Outcome of the event "hematoma in the area of administration" was unknown.
5mins post vaccination pt reported dizziness. Vitals: 123/89, 16, 96% -- > 130/91, 100, 16, 96% -- > 147/90, 110 Pt hydrated w/ water and given crackers.  Pt stable and released from the vaccination site.
she was unable to get an appointment for the 2nd shot due on 29Mar2021; dizziness; fever; This is a spontaneous report from a Pfizer Sponsored Program. A contactable female consumer(patient) reported for herself that: A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on 08Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications was not reported. On an unspecified date, the patient experienced she was unable to get an appointment for the 2nd shot due on 29Mar2021 and patient experienced dizziness and fever that might have missed her 2nd shot. The outcome of the events was reported as unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Day 1: Irritable. Hives appeared on torso and thighs. Gave her Benadryl. Day 2: PM - Hives spread to lower legs and feet/ankles.  Gave her Benadryl. Day 3: AM - Hives appeared on arm near armpit.  Hives on torso and legs decreasing.  Gave her Claritin. Day 4: Hives gone.
red all over the body, itchy; blotchy; lips feels like they are swelling up; red all over the body, itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red all over the body, itchy), RASH MACULAR (blotchy), LIP SWELLING (lips feels like they are swelling up) and PRURITUS (red all over the body, itchy) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red all over the body, itchy), RASH MACULAR (blotchy), LIP SWELLING (lips feels like they are swelling up) and PRURITUS (red all over the body, itchy). At the time of the report, ERYTHEMA (red all over the body, itchy), RASH MACULAR (blotchy), LIP SWELLING (lips feels like they are swelling up) and PRURITUS (red all over the body, itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
A few minutes after receiving the pfizer vaccine, patient noted some chest tightness and a weird feeling in her throat.  Blood pressure was 111/79 with a pulse of 79.  The feeling of chest tightness did not get worse or better.  No difficulty breathing. No change in color.  Second BP reading taken 5 minutes apart was same.
Patient had pre-existing occasional palpitations intermittently x several years felt to be due to PACs and PVCs, not requiring treatment.  After first dose of Pfizer COVID-19 vaccine, symptoms worsened in terms of frequency and severity of palpitations.  After second dose on 2/24/21, patient developed diverticulitis which required multiple course of oral antibiotics and ultimately 2 week course of IV antibiotics to resolve. By May 2021, her palpitations were much worse and were associated with fatigue, shortness of breath, and lightheadedness leadings to multiple ER visits.  Lab work was unremarkable including CBC, CMP, TSH and multiple EKGs and heart monitors showed only PACs, no serious arrhythmia noted.  Echocardiogram was normal other that moderate mitral regurg (EF was normal).  CXR was normal.  She also had stress echo done in January 2021 (just a few days after initial COVID-19 dose) which was negative for signs of ischemia.   Symptoms are persistent and worsening despite no obvious abnormalities on exam or testing.
Pts rxn started Tuesday night 1-15-13. Has swelling Rt arm from below injection sight to elbow. Painful. Taking BENADRYL & ibuprofen.
hives all over body x 3 days; rx DPh x 3 days;
Full body itching that resulted in hives. Went to health clinic and was diagnosed with dermotographia. Was prescribed antihistamines. If antihistamines are not taken, the itching and welts are extreme to the point of bleeding. It has been 3 months.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Additional Details: I could not reach her after the clinic.  I tried to call her phone to check on her.  She said her arm was itching after the 2nd shot and this area was away from the injection site.  Someone at the facility was going to give her some Benadryl to take.  I never heard from her again.  No anaphylactic signs were noted after the injection that I saw.  I was trying to get her Dr. info but she could not be reached.
Chest pain; Diarrhea; lymphadenopathy; This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (Chest pain), LYMPHADENOPATHY (lymphadenopathy) and DIARRHOEA (Diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain), LYMPHADENOPATHY (lymphadenopathy) and DIARRHOEA (Diarrhea). At the time of the report, CHEST PAIN (Chest pain), LYMPHADENOPATHY (lymphadenopathy) and DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Extreme nausea and vomiting for 3 days, muscle pain, 100.9 temperature
Not receiving 2nd dose on time; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Not receiving 2nd dose on time) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003f21a) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Sep-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not receiving 2nd dose on time). On 08-Sep-2021, PRODUCT DOSE OMISSION ISSUE (Not receiving 2nd dose on time) had resolved.            No concomitant medication reported. No treatment information was provided. The patient missed to attend the second dose appointment on 08-Sep-2021.
Immunization prep and administration were normal per protocol with no issues. Approximately 5 minutes after exiting the immunization room the patient approached the consultation window and stated he felt as if he were going to pass out. The pharmacist asked the patient to stay where he was and attempted to run around to the waiting area to help him sit. Before the pharmacist could make it to the patient he collapsed. The patient was in a seated position slumped against the wall, very pale, and profusely sweating. Pharmacist helped him to sit up straight and the patient started responding to questions. Other team members alerted EMS and got a water bottle for the patient. We moved him up to a chair and to the immunization area when he was able and waited for EMS to arrive. Patient was treated by EMS and left the building with them under his own power.